Race, Menopause and Metabolism After Exercise and Diet

Obesity Clinical Trial

Official title:

Menopause, Genes and Metabolism After Weight Loss and Exercise

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00882141
• Other study ID #: AG0116
• Secondary ID: RO1 AG19310R01AG
• Status: Completed
• Phase: N/A
• First received: April 15, 2009
• Last updated: January 11, 2010
• Start date: March 2002
• Est. completion date: December 2008

Study information

• Verified date: January 2010
• Source: National Institute on Aging (NIA)
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Federal Government
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to test the hypotheses that there are ethnic and genetic differences in the mechanisms and magnitude by which hypocaloric weight loss and aerobic exercise affect body composition, glucose, lipid, muscle and adipose tissue metabolism in overweight, insulin resistant postmenopausal women. This will be tested in a trial comparing the effects of weight loss vs. aerobic exercise plus weight loss on glucose, lipid, fat and muscle metabolism in overweight African American and Caucasian postmenopausal women.

Description:

The findings of this study will also determine whether there are racial differences in the whole body and cellular mechanisms by which aerobic exercise training and weight loss affect glucose, lipid, fat and muscle metabolism in African-American vs. Caucasian postmenopausal women. The results also may provide a rationale for targeting specific populations of women who might improve glucose, lipid, fat and muscle metabolism more from the addition of exercise to dietary restriction than weight loss alone to reduce their risk for type 2 diabetes and cardiovascular disease.

The study protocol consists of the following phases:

Phase 1—Recruitment and screening.

Phase 2—Weight and dietary stabilization for 4-6 weeks, where participants are taught the principles of the American Heart Association "Heart Healthy" diet and provided food to consume prior to testing.

Phase 3—Participants will undergo research testing including glucose clamp and fat biopsy.

Phase 4—Participants select either weight loss only, or exercise plus weight loss. The behavior diet modification weight loss sessions are held by a registered dietitian for 1 hour once a week for 6-9 months where the recommended caloric intake for each participant is adjusted by the dietitian to elicit a weight loss of approximately 0.2-0.4 kg per week. In addition to the weight loss sessions, participants who select the aerobic exercise plus weight loss intervention will exercise at the Baltimore Geriatric Research Education and Clinical Center (GRECC) exercise facility 3 times a week for 6-9 months using treadmills and other aerobic exercise equipment. Exercise sessions begin at low levels of VO2max (maximal oxygen consumption) and progress in duration and intensity until the participant is able to exercise at more than 75% VO2max for 45 minutes.

Phase 5—Following the 6-9 months of long-term weight loss or exercise plus weight loss, all participants will undergo long-term metabolic testing.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 103
• Est. completion date: December 2008
• Est. primary completion date: December 2008
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 45 Years to 80 Years

Eligibility

Inclusion Criteria:

• Female

• 45-80 yrs of age

• Non-smoking for one year

• BMI greater than 25 kg/m2 and less than 50 kg/m2

• Menopause over 1 year

• Caucasian or African American ethnicity

Exclusion Criteria:

Both groups

• Currently being treated for active cancer

• Type 1 diabetes; insulin treatment; poorly controlled (fasting blood sugar over 160 mg/dl)

• Allergic to lidocaine or heparin

• Untreated dyslipidemia, receiving triglyceride-lowering meds

• Other systemic disorders that are not medically treated and stable

• Taking beta-blockers, oral steroids, warfarin or any other medications interfering with fat/muscle metabolism that may not be safely discontinued temporarily for specific procedures (i.e. for 72 hours prior)

• Abnormal liver or renal function; chronic pulmonary disease (on supplemental oxygen); anemia

• MMSE (Mini-Mental State Examination) below 24, dementia or unstable clinical depression by exam

• Women of ethnicity other than Caucasian or African American

• Symptomatic heart disease, coronary artery disease, congestive heart failure, or uncontrolled hypertension unless medically stabilized

• Abnormal response to exercise test (chest pain, significant arrhythmias, extreme shortness of breath, cyanosis, exercising blood pressure above 240/120mm Hg, or other contraindications to exercise)

Exercise plus weight loss group only

• Medical history of CVD (cardiovascular disease) with symptoms limiting ability to exercise

• Physical impairment limiting normal activity

• Aerobically trained with VO2max greater than 2 SD (standard deviation) above age-adjusted mean

Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Insulin Resistance
• Obesity
• Sedentary Lifestyle

Intervention

Behavioral:
• Diet modification
Weight loss sessions are held by a registered dietitian for 1 hour once a week for 6-9 months; recommended caloric intake to elicit a weight loss of approximately 0.2-0.4 kg per week
• Aerobic exercise
Treadmills and other aerobic exercise equipment 3 times a week for 6-9 months, beginning at low levels of VO2max and progressing in duration and intensity to more than 75% VO2max for 45 minutes

Locations

Country	Name	City	State
United States	University of Maryland, VAMC	Baltimore	Maryland

Sponsors (1)

Lead Sponsor	Collaborator
National Institute on Aging (NIA)

Country where clinical trial is conducted

United States, 

References & Publications (4)

Berman DM, Rodrigues LM, Nicklas BJ, Ryan AS, Dennis KE, Goldberg AP. Racial disparities in metabolism, central obesity, and sex hormone-binding globulin in postmenopausal women. J Clin Endocrinol Metab. 2001 Jan;86(1):97-103. — View Citation

Nicklas BJ, Dennis KE, Berman DM, Sorkin J, Ryan AS, Goldberg AP. Lifestyle intervention of hypocaloric dieting and walking reduces abdominal obesity and improves coronary heart disease risk factors in obese, postmenopausal, African-American and Caucasian women. J Gerontol A Biol Sci Med Sci. 2003 Feb;58(2):181-9. — View Citation

Ryan AS, Nicklas BJ, Berman DM. Aerobic exercise is necessary to improve glucose utilization with moderate weight loss in women. Obesity (Silver Spring). 2006 Jun;14(6):1064-72. — View Citation

Ryan AS, Nicklas BJ, Berman DM. Racial differences in insulin resistance and mid-thigh fat deposition in postmenopausal women. Obes Res. 2002 May;10(5):336-44. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Glucose Clamp		At 4-6 weeks	No
Primary	Fat biopsy		At 4-6 weeks	No